Practical Approaches in the Management of Pulmonary Arterial Hypertension: Understanding the Pharmacist’s Role in Personalized Care

Program Description

Symptoms of pulmonary arterial hypertension (PAH) can significantly impact a person’s functional mobility, physical well-being, and their health-related quality of life. The management of patients with PAH requires a comprehensive and multidisciplinary treatment approach that includes the expertise of pharmacists to manage targeted drug treatment and supplemental therapies. In recent years, significant progress in the diagnosis, treatment, and management of PAH has led to new evidence-based recommendations included in the 2022 European Society of Cardiology and European Respiratory Society guidelines. Pharmacists must recognize the expanding landscape of therapeutic options in PAH, management considerations for preventing potential drug interactions and adverse events, and medication-specific considerations to support access and adherence. Along with a discussion of updated guideline recommendations for sequencing of approved and emerging therapies as well as data supporting utilization of early interventions with combination therapy, this program features opportunities to review practical cases and how to optimize coordination of care.

Target audience: Specialty pharmacists

Type of activity: Application
Release date: July 11, 2023
Expiration date: July 11, 2024

Time to complete activity: 1.0 hour

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explain the pathophysiology, clinical presentation, and impact on quality of life of pulmonary arterial hypertension (PAH)
• Investigate the safety and efficacy data of new and emerging treatment strategies for the management of PAH
• Identify the unique role of pharmacists in educating patients about the use of guideline-recommended therapies for the management of PAH and addressing barriers to optimal care
• Apply strategies to provide patients receiving treatment for the management of PAH with optimal care

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-299-H01-P. The activity is available for CE credit through July 11, 2024.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Tracy E. Macaulay, PharmD, BCCP, FACC, FCCP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms